Study Demonstrates Molecular Testing Superior to ELISA for Diagnosing Invasive Aspergillosis
NEW YORK (GenomeWeb) — Molecular testing methods such as nucleic acid sequence-based amplification (NASBA) and qPCR, administered either in combination or separately, are superior to routinely used ELISA-based assays for diagnosing invasive aspergillosis, according to a newly published retrospect
Irish clinical diagnostics company Trinity Biotech has acquired the blood bank screening and certain molecular assets of UK-based personalized medicine and clinical diagnostics firm Lab21, the companies said today.
BD Diagnostics, a segment of Becton Dickinson, and Lab 21 will develop the real-time PCR-based test as an in vitro diagnostic product.
Dec 9, 2010
Sep 9, 2010
Jan 13, 2010